Summit Therapeutics Inc.

Q2 2022 13F Holders

Symbol
SMMT
CUSIP
86627T108
Type
Equity
Class
COM
Num filings
43
Total reported value, excl. options
$8.46 M
Manager Report Date Value ($000) Shares Option Type